BioInnovation Institute thrives in Denmark The Novo Nordisk Foundation has established the BioInnovation Institute as an independent foundation and will provide up to 470 million euros ($570 million U.S.) over the next 10 years to support early-stage life science projects and startups.Read More
NoveCite touts preclinical results of COVID-19 allogenic stem cell therapy Citius Pharmaceuticals subsidiary NoveCite has released data from a proof-of-concept large animal study of its proprietary induced mesenchymal stem cell therapy for acute inflammatory respiratory conditions including acute respiratory distress syndrome related to COVID-19 disease.Read More
Bayer, Atara collaborate on CAR T-cell therapies Bayer and Atara Biotherapeutics have entered into an agreement to research, develop, manufacture, and license mesothelin-directed chimeric antigen receptor (CAR) T-cell therapies to treat solid tumors.Read More
Pfizer touts positive clinical data for bispecific antibody, gene therapy Pfizer has announced safety and clinical response results from its ongoing phase I study of its bispecific antibody for multiple myeloma. The company also updated follow-up data from a phase I/II study of SB-525/PF-07055480 (giroctocogene fitelparvovec), an investigational gene therapy for patients with severe hemophilia A.Read More